GENEVAC B INJECTION 1ML
Serum Institute Of India Ltd
HEPATITIS B IMMUNOGLOBULIN-20MCG
GENEVAC B INJECTION 1ML
GENEVAC B INJECTION 1ML belongs to the class of medication called 'biologics vaccines' or 'immunizing agent' used to prevent hepatitis B virus post-exposure. Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). It is given if you have not had previous vaccination, not properly vaccinated to hepatitis B virus, vaccinated but ineffective and are at risk of infection. It is also used for preventing infection in infants who are born to a hepatitis positive mother.
GENEVAC B INJECTION 1ML contains ‘hepatitis B immunoglobulin’ an antibody extracted from the plasma of the infected donor that acts against the hepatitis B virus (HBV). It does not provide long-term protection against hepatitis B infection. GENEVAC B INJECTION 1ML is not effective in HBs antigen-positive people (infected with the hepatitis B virus).
A GENEVAC B INJECTION 1ML is available as an injection and has to be given via intramuscular route only by a trained healthcare professional. GENEVAC B INJECTION 1ML may cause some common side-effects like swelling (oedema), redness, itching, bruising or hardening of the skin at the site of injection, low blood pressure, headache, dizziness, fast heart rate, being sick (vomiting), feeling sick (nausea), joint pains, back pain, fever, tiredness, and chills. Inform your doctor if any of these side-effects persist or get worsen.
Do not take GENEVAC B INJECTION 1ML if you are allergic to human hepatitis B immunoglobulin or any other biological antiviral vaccines or have had received immunoglobulin A but had an allergic reaction, and diagnosed with any blood disorders. Before taking GENEVAC B INJECTION 1ML, inform your doctor if you are taking any prescription or non-prescription medicines. Also, inform your doctor if you are pregnant or breastfeeding.
Hepatitis B infection
Store in a cool and dry place away from sunlight
Before taking GENEVAC B INJECTION 1ML, inform your doctor if you know that you have enough IgA antibodies (act against hepatitis A), previously diagnosed with hypertension (high blood pressure), diabetes, or blood clots, blood-related disorder, or heart disease, had vaccinations or planning to get vaccinated. Inform your doctor even if you just feel unwell after taking GENEVAC B INJECTION 1ML. Seek medical attention immediately develop pain, swelling, unusual warmth of a limb, sudden shortness of breath and chest pain worsening on deep breathing, weakness on one side, difficulty to speak, or confusion.
Alcohol may increase the risk of side-effects and worsen the hepatitis B condition.
GENEVAC B INJECTION 1ML is a category C drug. It should be used with caution in pregnant women as it may toxic effects on the unborn baby.
GENEVAC B INJECTION 1ML should be given to breastfeeding mothers only if clinically needed.
GENEVAC B INJECTION 1ML may not affect your ability to drive.
GENEVAC B INJECTION 1ML is used in patients with liver diseases when clinically needed.
GENEVAC B INJECTION 1ML can be safely used in patients with kidney diseases if prescribed.
This item is Not Returnable.
Expires on or after - September 2021
GENEVAC B INJECTION 1ML contains 'hepatitis B immunoglobulin' used to prevent hepatitis B infection (affects the liver). It works by neutralizing the hepatitis B virus by provoking an individual's immune system through cell-mediated immunity.
Do not take live vaccines such as MMR (measles, mumps, and rubella), typhoid, yellow fever, varicella (chickenpox), and zoster (shingles) vaccine while taking GENEVAC B INJECTION 1ML or for 3 months after taking GENEVAC B INJECTION 1ML. This medicine may alter the action of these vaccines.
GENEVAC B INJECTION 1ML may cause side-effects such as swelling, redness, itching, bruising or hardening of the skin at the site of injection, low blood pressure, headache, dizziness, fast heart rate, being sick (vomiting), feeling sick (nausea), joint pains, back pain, fever, tiredness, and chills.
It is given to people undergoing liver transplantation, who are exposed to infected blood products, who had sexual contact with an infected person, who are living with an infected person, or who are caring for an infected person. It is also given in babies born to mothers with hepatitis B.
The hepatitis B vaccine stimulates the immune system to produce antibodies against the hepatitis B virus (HBV) and also it provides long-term protection against the virus. On the other hand, hepatitis B immunoglobulin contains antibodies that act against HBV and it is given when immediate protection against the virus is needed.
1 ml Injection in 1 Vial